Reimagining Biotechnology

Abstract: Biotechnology is in a transition from artisanal tools and methods to computer-controlled, high-throughput systems that allow research and development at industrial scale. This digitization is also radically reducing technical and economic barriers, empowering a new generation of young designers to do bioengineering on par with major companies but at a fraction of the cost, and prompting a re-think of the entire industry, including business models, intellectual property, ethics and biosecurity. This shift has the potential to disrupt R&D on a global scale. This lecture provides an overview of the issues and opportunities.

About the Speaker: Autodesk Distinguished Researcher Andrew Hessel is spearheading the development of tools and processes that facilitate the computer-aided design and computer-aided manufacture of living creatures and systems. As a 2015-2016 AAAS-Lemelson Invention Ambassador, he also encourages others to explore invention and innovation in biological engineering. Andrew is active in the iGEM and DIYbio (do-it-yourself) communities and frequently works with students and young entrepreneurs to guide their career and business development efforts. He has given hundreds of invited talks on synthetic biology to groups that include hollywood movie producers, the United Nations, and the FBI.